Blinded Cross-Over Bioequivalence (BE) Trial of Luitpold Azacitidine vs Vidaza

Clinical trial NCT01290302 · COMPLETED

Trial details

NCT number: NCT01290302
Sponsor: American Regent, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Myelodysplastic Syndrome Myelofibrosis Chronic Myeloid Leukemia Chronic Lymphocytic Leukemia

Start date: 2010-11-22
Primary completion: 2012-12-01
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.